logo
Hyperglycemia: a prothrombotic factor?
Hageman factor, platelets and polyphosphates: early history and recent connection
Patent foramen ovale (PFO) and cryptogenic stroke
Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data
Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy
Novel mutations in leukotriene C4 synthase and risk of cardiovascular disease based on genotypes from 50 000 individuals
Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies
Venous thromboembolism and subsequent diagnosis of subarachnoid hemorrhage: a 20-year cohort study
Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies
A nationwide, retrospective analysis of symptoms, comorbidities, medical care and autopsy findings in cases of fatal pulmonary embolism in younger patients
Risk factors for peripheral venous disease resemble those for venous thrombosis: the San Diego Population Study
The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy
Anticoagulation by factor Xa inhibitors
Redox control of β2-glycoprotein I–von Willebrand factor interaction by thioredoxin-1
Characterization of canine coagulation factor VII and its complex formation with tissue factor: canine–human cross-species compatibility
Generation of a novel factor IX with augmented clotting activities in vitro and in vivo
Clinical proteomics in platelet research: challenges ahead
The α-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome
Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization
Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes
Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel
A heparin mimetic isolated from a marine shrimp suppresses neovascularization
17α-Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor α
Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices
Calibration of the WHO 1st International Standard and SSC/ISTH Secondary Coagulation Standard for Tissue Plasminogen Activator Antigen in Plasma
No association between chromosome 12p13 single nucleotide polymorphisms and early-onset ischemic stroke
Plasma and IgGs from patients with lupus anticoagulant induce tissue factor in monocytes: a possible risk factor for thrombosis
Effect of protein disulfide isomerase chaperone activity inhibition on tissue factor activity
Mutation analysis for a patient with Glanzmann thrombasthenia who produced a landmark isoantibody to the αIIbβ3 integrin
When a virtue becomes a problem. The new oral anticoagulants
Computational candidate gene prioritization for venous thrombosis
Surveillance duplex scanning to prevent venous thromboembolism: does it make a difference in rehabilitation unit patients?
Association between deep vein thrombosis and transient inflammatory signs and symptoms: a case–control study
Fondaparinux as an alternative anticoagulant therapy during pregnancy
High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients
Join ISTH